Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/171765
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPelletier, Joffrey-
dc.contributor.authorRiaño Canalias, Ferran-
dc.contributor.authorAlmacellas i Canals, Eugènia-
dc.contributor.authorMauvezin, Caroline-
dc.contributor.authorSamino Gené, Sara-
dc.contributor.authorFeu i Coll, Sònia-
dc.contributor.authorMenoyo, Sandra-
dc.contributor.authorDomostegui Fernández, Ana-
dc.contributor.authorGarcía Cajide, Marta-
dc.contributor.authorSalazar Soler, Ramón-
dc.contributor.authorCortés, Constanza-
dc.contributor.authorMarcos, Ricard-
dc.contributor.authorTauler Girona, Albert-
dc.contributor.authorYanes, Oscar-
dc.contributor.authorAgell i Jané, Neus-
dc.contributor.authorKozma, Sara C.-
dc.contributor.authorGentilella, Antonio-
dc.contributor.authorThomas, George-
dc.date.accessioned2020-11-05T12:08:24Z-
dc.date.issued2020-06-02-
dc.identifier.issn0261-4189-
dc.identifier.urihttp://hdl.handle.net/2445/171765-
dc.description.abstractMany oncogenes enhance nucleotide usage to increase ribosome content, DNA replication, and cell proliferation, but in parallel trigger p53 activation. Both the impaired ribosome biogenesis checkpoint (IRBC) and the DNA damage response (DDR) have been implicated in p53 activation following nucleotide depletion. However, it is difficult to reconcile the two checkpoints operating together, as the IRBC induces p21‐mediated G1 arrest, whereas the DDR requires that cells enter S phase. Gradual inhibition of inosine monophosphate dehydrogenase (IMPDH), an enzyme required for de novo GMP synthesis, reveals a hierarchical organization of these two checkpoints. We find that the IRBC is the primary nucleotide sensor, but increased IMPDH inhibition leads to p21 degradation, compromising IRBC‐mediated G1 arrest and allowing S phase entry and DDR activation. Disruption of the IRBC alone is sufficient to elicit the DDR, which is strongly enhanced by IMPDH inhibition, suggesting that the IRBC acts as a barrier against genomic instability.-
dc.format.extent19 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherEMBO Press-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.15252/embj.2019103838-
dc.relation.ispartofThe EMBO Journal, 2020, vol. 39, num. 13, p. e103838-
dc.relation.urihttps://doi.org/10.15252/embj.2019103838-
dc.rightscc by (c) Pelletier, Joffrey et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)-
dc.subject.classificationReparació de l'ADN-
dc.subject.classificationRibosomes-
dc.subject.classificationNucleòtids-
dc.subject.otherDNA repair-
dc.subject.otherRibosomes-
dc.subject.otherNucleotides-
dc.titleNucleotide depletion reveals the impaired ribosomebiogenesis checkpoint as a barrier against DNA damage-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec701722-
dc.date.updated2020-11-05T12:08:24Z-
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/799000/EU//M-Lysosomes-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid32484960-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Publicacions de projectes de recerca finançats per la UE
Articles publicats en revistes (Bioquímica i Fisiologia)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
701722.pdf3.11 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons